3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Pleural Effusion, Malignant
5
Neoplasm Metastasis
4
Solitary Fibrous Tumor, Pleural
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Diseases
1
Interventions
Cisplatin
6
Pemetrexed
4
Carboplatin
3
Nivolumab
2
Ipilimumab
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
ranpirnase
1
raltitrexed
1
durvalumab
1
atezolizumab
1
Vinorelbine
1
Vincristine
1
Talc
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Psychiatric Rehabilitation
1
Platinum
1
Mitomycin
1
Injections
1
Gemcitabine
1
Fentanyl
1
Drug Therapy
1
Doxorubicin
1
Cerebral Decortication
1
Analgesia
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Mesothelioma, Malignant
×
Talc
×
Clear all
NCT00821860
2013-06-28
MesoVATS
Papworth Hospital NHS Foundation Trust
Phase 3
Completed
196 enrolled